Standard BioTools Inc. Common Stock LAB
i
Market dataready · fetched 2026-11-03T14:41:31.975Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-03T14:41:29.216148631Z
FundamentalsSEC EDGAR · ready · as of 2026-06-30 · fetched 2026-11-03T14:41:30.683252+00:00
Standard BioTools Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 0.58 | 775.8% | 75.6% | |||
| 25Δ | 0.68 | 744.2% | 70.3% | |||
| 30Δ | 0.92 | 292.0% | 62.9% | 0.79 | 712.6% | 64.9% |
| 35Δ | 0.88 | 333.3% | 60.9% | 0.89 | 681.0% | 59.6% |
| 40Δ | 0.84 | 374.5% | 59.0% | 0.99 | 649.4% | 54.3% |
| 45Δ | 0.80 | 415.8% | 57.0% | 1.09 | 617.8% | 49.0% |
| 50Δ | 0.76 | 457.1% | 55.0% | 1.20 | 586.2% | 43.7% |
| 55Δ | 0.72 | 498.3% | 53.1% | 1.30 | 554.6% | 38.4% |
| 60Δ | 0.68 | 539.6% | 51.1% | 1.40 | 523.0% | 33.1% |
| 65Δ | 0.64 | 580.9% | 49.2% | 1.51 | 491.4% | 27.8% |
| 70Δ | 0.60 | 622.1% | 47.2% | 1.61 | 459.8% | 22.4% |
| 75Δ | 0.56 | 663.4% | 45.2% | 1.71 | 428.2% | 17.1% |
| 80Δ | 0.52 | 704.7% | 43.3% | 1.82 | 396.6% | 11.8% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 0.58
- IV
- 775.8%
- B/E move
- 75.6%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 0.68
- IV
- 744.2%
- B/E move
- 70.3%
30Δ
- Pseudo strike
- 0.92
- IV
- 292.0%
- B/E move
- 62.9%
- Pseudo strike
- 0.79
- IV
- 712.6%
- B/E move
- 64.9%
35Δ
- Pseudo strike
- 0.88
- IV
- 333.3%
- B/E move
- 60.9%
- Pseudo strike
- 0.89
- IV
- 681.0%
- B/E move
- 59.6%
40Δ
- Pseudo strike
- 0.84
- IV
- 374.5%
- B/E move
- 59.0%
- Pseudo strike
- 0.99
- IV
- 649.4%
- B/E move
- 54.3%
45Δ
- Pseudo strike
- 0.80
- IV
- 415.8%
- B/E move
- 57.0%
- Pseudo strike
- 1.09
- IV
- 617.8%
- B/E move
- 49.0%
50Δ
- Pseudo strike
- 0.76
- IV
- 457.1%
- B/E move
- 55.0%
- Pseudo strike
- 1.20
- IV
- 586.2%
- B/E move
- 43.7%
55Δ
- Pseudo strike
- 0.72
- IV
- 498.3%
- B/E move
- 53.1%
- Pseudo strike
- 1.30
- IV
- 554.6%
- B/E move
- 38.4%
60Δ
- Pseudo strike
- 0.68
- IV
- 539.6%
- B/E move
- 51.1%
- Pseudo strike
- 1.40
- IV
- 523.0%
- B/E move
- 33.1%
65Δ
- Pseudo strike
- 0.64
- IV
- 580.9%
- B/E move
- 49.2%
- Pseudo strike
- 1.51
- IV
- 491.4%
- B/E move
- 27.8%
70Δ
- Pseudo strike
- 0.60
- IV
- 622.1%
- B/E move
- 47.2%
- Pseudo strike
- 1.61
- IV
- 459.8%
- B/E move
- 22.4%
75Δ
- Pseudo strike
- 0.56
- IV
- 663.4%
- B/E move
- 45.2%
- Pseudo strike
- 1.71
- IV
- 428.2%
- B/E move
- 17.1%
80Δ
- Pseudo strike
- 0.52
- IV
- 704.7%
- B/E move
- 43.3%
- Pseudo strike
- 1.82
- IV
- 396.6%
- B/E move
- 11.8%
Options history
No recorded observations
Medical Devices
LIVN
LivaNova PLC, a medical device company, designs, develops, manufactures and sells therapeutic solutions globally. The company is headquartered in London, the United Kingdom.
More →LNSR
LENSAR, Inc., a commercial stage medical device company, is focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and…
More →LUNG
Pulmonx Corporation, a medical technology company, designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic…
More →MASS
908 Devices Inc. develops and sells measuring devices for chemical and biochemical analysis in North America, Europe, the Middle East, Africa, and Asia Pacific. The company is…
More →MBOT
Microbot Medical Inc., a preclinical medical device company, researches, designs and develops micro-robotic-assisted medical technologies targeting the minimally invasive surgery…
More →MDT
Description unavailable
More →